Despite recent advances in both prevention and treatment, hepatitis remains a significant problem in the world today.  According to the World Health Organization, each year an estimated 1.4 million new cases of hepatitis A occur, and more than 780,000 people die as a consequence of hepatitis B.   Effective vaccination is the first line of defense for these viruses.

Featured Articles

Yes Hepatitis B control in the World Health Organization’s Western Pacific Region: Targets, strategies, status
Karen Hennessey, Jorge Mendoza-Aldana, Benjamin Bayutas, et al

WHO’s Western Pacific Region has the highest rates of hepatitis B virus (HBV) infection in the world; most countries have >8% prevalence of HBV...

Yes Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: Results from China GAVI project final evaluation
Fuqiang Cui, Huiming Luo, Fuzhen Wang, et al

Mother to Child Transmission (MTCT) has remained a leading cause of HBV infection in China, accounting for 40% of total infections.

No Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review
Sarah F. Schillie, Trudy V. Murphy

Hepatitis B vaccination starting at birth provides a safety net for infants exposed to hepatitis B virus (HBV) during delivery or in early life....

Yes WHO position paper on hepatitis A vaccines: June 2012—Recommendations
Meeting Report

This article presents the World Health Organizations (WHO) recommendations on the use of hepatitis A vaccine excerpted from the WHO position paper...